On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Friends Research Institute

InstitutionResearch output, impact & collaborations

Friends Research Institute is a institution indexed in ScholarIQ from OpenAlex.

What is known about Friends Research Institute?

ScholarIQrecord summary

Friends Research Institute is a research organisation in Baltimore, US. OpenAlex records 1,051 works and 72,714 citations for it. 164 researchers list it as their most recent affiliation.

How many works does Friends Research Institute have?

ScholarIQindexed works

Friends Research Institute has 1,051 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Friends Research Institute have?

ScholarIQcitation count

Friends Research Institute has 72,714 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Friends Research Institute?

ScholarIQresearcher count

Friends Research Institute has 164 researchers in the ScholarIQ index.

What is the average h-index at Friends Research Institute?

ScholarIQavg h-index

Friends Research Institute has an average h-index of 75.5 in OpenAlex.

What is the ROR of Friends Research Institute?

ScholarIQror

The ROR for Friends Research Institute is on the source record.

What is the OpenAlex record for Friends Research Institute?

ScholarIQopenalex

The OpenAlex for Friends Research Institute is on the source record.

Who are the most-cited researchers behind Friends Research Institute?

ScholarIQtop researchers by citations
1
Michael S. Gordon · Cancer Immunotherapy and Biomarkers
570 works28,331 citations
2
Maxine L. Stitzer · Substance Abuse Treatment and Outcomes
562 works20,290 citations

What are the most-cited papers on Friends Research Institute?

ScholarIQmost cited works
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
Jeffrey R. Infante, Leslie A. Fecher, Gerald S. Falchook, Sujatha Nallapareddy, Michael S. Gordon, Carlos Becerra, Douglas J. DeMarini, Donna S. Cox, Yanmei Xu, Shannon R. Morris, Vijay Peddareddigari, Ngocdiep T. Le, Lowell L. Hart, Johanna C. Bendell, Gail Eckhardt, Razelle Kurzrock, Keith T. Flaherty, Howard A. Burris, Wells A. Messersmith
The Lancet Oncology. 2012559 Citations
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
Gerald S. Falchook, Karl D. Lewis, Jeffrey R. Infante, Michael S. Gordon, Nicholas J. Vogelzang, Douglas J. DeMarini, Peng Sun, Christopher Moy, Stephen A. Szabo, Lori Roadcap, Vijay Peddareddigari, Peter F. Lebowitz, Ngocdiep T. Le, Howard A. Burris, Wells A. Messersmith, Peter J. O’Dwyer, Kevin B. Kim, Keith T. Flaherty, Johanna C. Bendell, René González, Razelle Kurzrock, Leslie A. Fecher
The Lancet Oncology. 2012545 CitationsOPEN ACCESS
Neuropsychopharmacology
Anne M. Andrews, Greg A. Gerhardt, Lynette C. Daws, Mohammed Shoaib, Barbara J. Mason, Charles J. Heyser, Luı́s de Lecea, Robert L. Balster, Sharon Walsh, Megan M. Dahmen, Jana Lincoln, Sheldon Preskorn, Roshan Cools, María Isabel Colado, Richard Green, Luis Stinus, Stéphanie Caillé, Martine Cador, Marie-Louise G. Wadenberg, Samuel G. Siris, Seiya Miyamoto, Alex Hofer, Linda P. Spear, A. Claudio Cuello, A. Leslie Morrow, Patrizia Porcu, Marilyn E. Carroll, Peter A. Santi, Daniel Bertrand, Hans Rollema, Raymond S Hurst, Peter Riederer, Siegfried Hoyer, Wiepke Cahn, Heleen B. M. Boos, H D Postma, R. H. De Rijk, E. R Kloet, Sharon Morein‐Zamir, Barbara J. Sahakian, Peter Riederer, Siegfried Hoyer, J. M. Bessa, Osborne F. X. Almeida, N. Sousa, Wiepke Cahn, Heleen B. M. Boos, H D Postma, R. Andrew Chambers, Caroline Cohen, Marc Turiault, Guy Griebel, Caroline Cohen, Marc Turiault, Guy Griebel, Wolfgang Fleischhacker, Alfonso Abizaid, Shimon Amir, Jaanus Harro, Peter Verheart, Per Svenningsson, Per E. Andrén, R. Andrew Chambers, Kenneth J. Rhodes, A. Richard Green, María Isabel Colado, María Isabel Colado, Richard Green, Christof Baltes, Thomas Mueggler, Markus Rudin, Lucy C. Guillory, Becky Kinkead, Charles B. Nemeroff, Wiepke Cahn, Heleen B. M. Boos, H D Postma, Heleen B. M. Boos, H. D. Postma, Wiepke Cahn, Stephen B. Dunnett, Michael J. Kuhar, Anne M. Andrews, Greg A. Gerhardt, Lynette C. Daws, Stephen M. Stahl, Meghan M. Grady, Jean‐Michel Scherrmann, Arthur Christopoulos, Gregory D. Stewart, Patrick M. Sexton, Jelena Nešić, Theodora Duka, Paul B. S. Clarke, Maxine L. Stitzer, Daniel Bertrand, Hans Rollema, Raymond S Hurst, Hans Rollema, Daniel Bertrand
2010323 Citations
Effects of Lower-Cost Incentives on Stimulant Abstinence in Methadone Maintenance Treatment
Jessica M. Peirce, Nancy M. Petry, Maxine L. Stitzer, Jack Blaine, Scott Kellogg, Frank Satterfield, Marion Schwartz, Joe Krasnansky, Eileen Pencer, Lolita Silva-Vazquez, Kimberly C. Kirby, Charlotte Royer-Malvestuto, John M. Roll, Allan Cohen, Marc L. Copersino, Ken Kolodner, Rui Li
Archives of General Psychiatry. 2006308 Citations
A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.
Isidore Tepler, Laurence Elias, John W. Smith, Mohamad A. Hussein, Gerald Rosen, A. Y. Chang, Joseph O. Moore, Michael S. Gordon, Bernice Kuca, Kathleen J. Beach, John W. Loewy, Marc B. Garnick, James A. Kaye
PubMed. 1996305 Citations

How much of the research on Friends Research Institute is open access?

ScholarIQopen access share
20%OPEN ACCESS
Gold
0%
Green
20%
Hybrid
0%
Bronze
0%
Closed
80%

Related on ScholarIQ

470M+ articles · 14-day free trial